/Investors

ReGen Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

circecircebioscience.comOct 2021

Circe develops a biotechnology platform that uses advanced gas transformation to produce carbon-negative molecules at scale for manufacturing.

Advanced ManufacturingBiotechCleantechClimate TechBoston, US

Marika Ziesack(Executive Officer, Director, Promoter)Shannon Nangle(Founder)in

Co-investorsBee PartnersE8 AngelsElementum VenturesExceptional VenturesJuniperSilicon Valley+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.